STING1 and infection: In line with this hypothesis, pre-treatment with the STING agonist ADU-S100 decreased the susceptibility of moDCs to HCMV-NG infection, whereas treatment at the time of virus exposure significantly increased percentages of NG+ moDCs (Fig. 4f).